2026/2668(DEA)
Infection with bluetongue virus (serotypes 1-24) and infection with epizootic haemorrhagic disease virus and introducing a derogation for movements of registered equine animals
Basic information
2026/2668(DEA)
DEA - Delegated acts procedure
Supplementing 2013/0136(COD)
Subject
3.10.08.05 Animal diseases
4.20.01 Medicine, diseases
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed Committee for opinion Rapporteur for opinion Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 27/03/2026 | Non-legislative basic document published | C(2026)00901 | |
| 27/03/2026 | Initial period for examining delegated act 2 month(s) | ||
| 29/04/2026 | Committee referral announced in Parliament | ||
| 13/05/2026 | Initial period for examining delegated act extended at Parliament's request by 2 month(s) | ||
| 11/09/2026 | Delegated act not objected by Parliament |
Technical information
| Procedure reference | 2026/2668(DEA) |
|---|---|
| Procedure type | DEA - Delegated acts procedure |
| Procedure subtype | Examination of delegated act |
| Amendments and repeals | Supplementing 2013/0136(COD) |
| Legal basis | Rules of Procedure EP 114-p03 |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
AGRI/10/05526
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2026)00901 27/03/2026 Document attached to the procedure C(2026)5594 29/07/2026
Additional information
| Source | Document | Date |
|---|---|---|
| European Commission | EUR-Lex |